Next Article in Journal
Radioreparative Effect of Diode Laser on Leukopoiesis Recovery: A Pilot Study
Next Article in Special Issue
VacStent as an Innovative Approach in the Treatment of Anastomotic Insufficiencies and Leakages in the Gastrointestinal Tract—Review and Outlook
Previous Article in Journal
Objective Non-Invasive Bio-Parametric Evaluation of Regenerated Skin: A Comparison of Two Acellular Dermal Substitutes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

The Triple-S Advantage of Endoscopic Management in Gastrointestinal Surgery Complications: Safe, Successful, and Savings-Driven

by
Francesco Vito Mandarino
1,*,
Emanuele Sinagra
2,
Alberto Barchi
1 and
Silvio Danese
1
1
Department of Gastroenterology and Gastrointestinal Endoscopy, Scientific Institute San Raffaele, Vita-Salute San Raffaele University, 20132 Milan, Italy
2
Gastroenterology and Endoscopy Unit, Fondazione Istituto San Raffaele Giglio, 90015 Cefalù, Italy
*
Author to whom correspondence should be addressed.
Life 2024, 14(1), 122; https://doi.org/10.3390/life14010122
Submission received: 30 November 2023 / Accepted: 12 January 2024 / Published: 15 January 2024
Despite advances in gastrointestinal (GI) surgery, post-operative complications are not entirely avoidable. Esophagectomy, a major GI surgical intervention, is still associated with post-operative adverse events in 59–63.9% of cases [1,2,3], with a third being classified with a Clavian–Dindo grade greater than IIIB [4], and the post-operative mortality rate ranging between 4 and 11% [1,2,3]. In such scenarios, a redo surgery, which is extremely costly and invasive, exposes patients who are already fragile due to underlying diseases and clinical conditions to a high risk of morbidity and mortality. With the aim of avoiding redo surgery, endoscopy has seen significant progress in recent years and is now considered the treatment of choice for most complications following GI surgery.
For post-esophagectomy anastomotic leaks (ALs), Self-Expandable Metal Stents (SEMSs) have been the preferred endoscopic treatment (ET) for years. SEMSs have shown high success rates, ranging from 62% to 90% [5,6], although their use is associated with some adverse events, particularly migration, which occurs in up to 23% of cases [6]. Endoscopic Vacuum Therapy (EVT) has shown higher success rates in treating post-esophagectomy ALs, ranging between 82% and 95%, with a lower rate of complications [7,8,9,10,11]. Furthermore, it has been proven effective as a rescue therapy [12] and for preventive purposes [13]. In recent years, the VAC stent, a new device combining the benefits of EVT and SEMSs, has demonstrated promising results [14,15,16]. Further prospective studies will be needed to validate its efficacy. Other devices that are used for ET of ALs following GI surgery, including bariatric surgery [17], comprise the over-the-scope clip (OTSC) [18], fibrin glue [19], and the Overstitch system [20].
Endoscopic dilatation (ED) is the primary treatment for benign post-esophagectomy and gastrectomy strictures [21,22]. Robust data have demonstrated that balloon and Savary–Gilliard dilators are equally effective in this setting [23]. The most recent guidelines recommend dilation of the esophageal lumen to >14–15 mm as the target for symptomatic improvement [24,25]. In cases of refractory strictures, defined as those where a luminal diameter of >14 mm is not achieved after five sessions of endoscopic dilation at 2-week intervals, the ET algorithm includes intralesional steroid injection, intralesional mitomycin C injection, incisional therapy, or esophageal stent placement (SEMSs or biodegradable) [26,27].
Delayed gastric emptying (DGE) is a common complication after esophagectomy, occurring in about 15% of patients, and can drastically reduce the quality of life by causing malnutrition. DGE is mainly due to the bilateral disconnection of the vagus nerve and the damage to the celiac plexus during surgery, as well as the development of a different pressure gradient in the gastric tubule, which is brought into the thoracic cavity [28]. Targeting the pylorus to treat DGE has represented a revolution in the management of this complication. Several endoscopic treatments have been developed over time, including botulinum toxin injection [29,30], pylorus balloon dilatation [29], and peroral endoscopic myotomy (G-POEM) [31,32], with symptom improvement achieved in up to 85% of patients after the treatment [29].
Endoscopy is also effective in treating post-operative anastomotic bleeding. Through-the-scope (TTS) clips, OTSC, and injection therapy are the available tools for managing this adverse event [33].
ET of complications following GI surgery is now considered successful, safe, and cost-effective.
The treatment is effective, as reported, for anastomotic leaks, strictures, bleeding and post-surgery motility disorders. The adaptability and versatility of endoscopy facilitate the customization of procedures for individual patients, enhancing the rate of successful outcomes.
Endoscopy, by definition, avoids the risk of physical trauma, unlike a redo surgery. Enhanced precision, enabled by advanced imaging, targeting of affected areas accurately, and reducing the risk of damaging adjacent tissues are considerable advantages of this treatment. Additionally, ET implies a lower anesthetic risk, allowing for moderate or deep sedation instead of general anesthesia in some conditions.
In terms of cost-effectiveness, ET often requires less operating time and resources, which translates to lowering the overall cost. In cases of scheduled treatment, this leads to reduced hospital stays and greater patient satisfaction.
The world of ET of post-GI surgery complications is evolving, and in the future, it could be enriched by translational approaches. Evidence from patients’ microbiota might predict patients who are at risk of anastomotic dehiscence and suggest prophylactic treatments or interventions to modify the bacterial flora [34,35,36,37].
In this Special Issue, we invite submissions of papers analyzing ET of complications after malignant and benign gastrointestinal surgery. The objective is to present further evidence and reinforce the notion of endoscopy as a frontline approach in treating such complications, thereby enhancing patient outcomes.

Author Contributions

Conceptualization, F.V.M.; writing—original draft preparation, F.V.M., E.S. and A.B.; supervision, S.D. All authors have read and agreed to the published version of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Low, D.E.; Kuppusamy, M.K.; Alderson, D.; Cecconello, I.; Chang, A.C.; Darling, G.; Davies, A.; D’Journo, X.B.; Gisbertz, S.S.; Griffin, S.M.; et al. Benchmarking Complications Associated with Esophagectomy. Ann. Surg. 2019, 269, 291–298. [Google Scholar] [CrossRef] [PubMed]
  2. Linden, P.A.; Towe, C.W.; Watson, T.J.; Low, D.E.; Cassivi, S.D.; Grau-Sepulveda, M.; Worrell, S.G.; Perry, Y. Mortality After Esophagectomy: Analysis of Individual Complications and Their Association with Mortality. J. Gastrointest. Surg. 2020, 24, 1948–1954. [Google Scholar] [CrossRef] [PubMed]
  3. Steyerberg, E.W.; Neville, B.A.; Koppert, L.B.; Lemmens, V.E.; Tilanus, H.W.; Coebergh, J.-W.W.; Weeks, J.C.; Earle, C.C. Surgical mortality in patients with esophageal cancer: Development and validation of a simple risk score. J. Clin. Oncol. 2006, 24, 4277–4284. [Google Scholar] [CrossRef]
  4. Dindo, D.; Demartines, N.; Clavien, P.-A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 2004, 240, 205–213. [Google Scholar] [CrossRef] [PubMed]
  5. Mandarino, F.V.; Esposito, D.; Spelta, G.N.E.; Cavestro, G.M.; Rosati, R.; Parise, P.; Gemma, M.F.; Fanti, L. Double layer stent for the treatment of leaks and fistula after upper gastrointestinal oncologic surgery: A retrospective study. Updat. Surg. 2022, 74, 1055–1062. [Google Scholar] [CrossRef]
  6. Aryaie, A.H.; Singer, J.L.; Fayezizadeh, M.; Lash, J.; Marks, J.M. Efficacy of endoscopic management of leak after foregut surgery with endoscopic covered self-expanding metal stents (SEMS). Surg. Endosc. 2017, 31, 612–617. [Google Scholar] [CrossRef]
  7. Zhang, C.C.; Liesenfeld, L.; Klotz, R.; Koschny, R.; Rupp, C.; Schmidt, T.; Diener, M.K.; Müller-Stich, B.P.; Hackert, T.; Sauer, P.; et al. Feasibility, effectiveness, and safety of endoscopic vacuum therapy for intrathoracic anastomotic leakage following transthoracic esophageal resection. BMC Gastroenterol. 2021, 21, 72. [Google Scholar] [CrossRef] [PubMed]
  8. Chon, S.-H.; Brunner, S.; Müller, D.T.; Lorenz, F.; Stier, R.; Streller, L.; Eckhoff, J.; Straatman, J.; Babic, B.; Schiffmann, L.M.; et al. Time to endoscopic vacuum therapy—Lessons learned after > 150 robotic-assisted minimally invasive esophagectomies (RAMIE) at a German high-volume center. Surg. Endosc. 2023, 37, 741–748. [Google Scholar] [CrossRef]
  9. Mandarino, F.V.; Barchi, A.; D’Amico, F.; Fanti, L.; Azzolini, F.; Viale, E.; Esposito, D.; Rosati, R.; Fiorino, G.; Bemelman, W.A.; et al. Endoscopic Vacuum Therapy (EVT) versus Self-Expandable Metal Stent (SEMS) for Anastomotic Leaks after Upper Gastrointestinal Surgery: Systematic Review and Meta-Analysis. Life 2023, 13, 287. [Google Scholar] [CrossRef]
  10. Chon, S.-H.; Berlth, F.; Dratsch, T.; Plum, P.S.; Lorenz, F.; Goeser, T.; Bruns, C.J. Outcome of prophylactic endoscopic vacuum therapy for high-risk anastomosis after esophagectomy. Minim. Invasive Ther. Allied Technol. 2022, 31, 1079–1085. [Google Scholar] [CrossRef]
  11. Mandarino, F.V.; Barchi, A.; Leone, L.; Fanti, L.; Azzolini, F.; Viale, E.; Esposito, D.; Salmeri, N.; Puccetti, F.; Barbieri, L.; et al. Endoscopic vacuum therapy versus self-expandable metal stent for treatment of anastomotic leaks < 30 mm following oncologic Ivor-Lewis esophagectomy: A matched case–control study. Surg. Endosc. 2023, 37, 7039–7050. [Google Scholar] [CrossRef]
  12. Mandarino, F.V.; Barchi, A.; Fanti, L.; D’amico, F.; Azzolini, F.; Esposito, D.; Biamonte, P.; Lauri, G.; Danese, S. Endoscopic vacuum therapy for post-esophagectomy anastomotic dehiscence as rescue treatment: A single center case series. Esophagus 2022, 19, 417–425. [Google Scholar] [CrossRef] [PubMed]
  13. Mandarino, F.V.; Barchi, A.; Biamonte, P.; Esposito, D.; Azzolini, F.; Fanti, L.; Danese, S. The prophylactic use of endoscopic vacuum therapy for anastomotic dehiscence after rectal anterior resection: Is it feasible for redo surgery? Tech. Coloproctol. 2022, 26, 319–320. [Google Scholar] [CrossRef] [PubMed]
  14. Lange, J.; Dormann, A.; Bulian, D.R.; Hügle, U.; Eisenberger, C.F.; Heiss, M.M. VACStent: Combining the benefits of endoscopic vacuum therapy and covered stents for upper gastrointestinal tract leakage. Endosc. Int. Open 2021, 9, E971–E976. [Google Scholar] [CrossRef] [PubMed]
  15. Chon, S.-H.; Bartella, I.; Bürger, M.; Rieck, I.; Goeser, T.; Schröder, W.; Bruns, C.J. VACStent: A new option for endoscopic vacuum therapy in patients with esophageal anastomotic leaks after upper gastrointestinal surgery. Endoscopy 2020, 52, E166–E167. [Google Scholar] [CrossRef]
  16. Chon, S.-H.; Scherdel, J.; Rieck, I.; Lorenz, F.; Dratsch, T.; Kleinert, R.; Gebauer, F.; Fuchs, H.F.; Goeser, T.; Bruns, C.J. A new hybrid stent using endoscopic vacuum therapy in treating esophageal leaks: A prospective single-center experience of its safety and feasibility with mid-term follow-up. Dis. Esophagus 2022, 35, doab067. [Google Scholar] [CrossRef]
  17. Rogalski, P.; Swidnicka-Siergiejko, A.; Wasielica-Berger, J.; Zienkiewicz, D.; Wieckowska, B.; Wroblewski, E.; Baniukiewicz, A.; Rogalska-Plonska, M.; Siergiejko, G.; Dabrowski, A.; et al. Endoscopic management of leaks and fistulas after bariatric surgery: A systematic review and meta-analysis. Surg. Endosc. 2021, 35, 1067–1087. [Google Scholar] [CrossRef]
  18. Hagel, A.F.; Naegel, A.; Lindner, A.S.; Kessler, H.; Matzel, K.; Dauth, W.; Neurath, M.F.; Raithel, M. Over-the-Scope Clip Application Yields a High Rate of Closure in Gastrointestinal Perforations and May Reduce Emergency Surgery. J. Gastrointest. Surg. 2012, 16, 2132–2138. [Google Scholar] [CrossRef]
  19. Lippert, E.; Klebl, F.H.; Schweller, F.; Ott, C.; Gelbmann, C.M.; Schölmerich, J.; Endlicher, E.; Kullmann, F. Fibrin glue in the endoscopic treatment of fistulae and anastomotic leakages of the gastrointestinal tract. Int. J. Color. Dis. 2011, 26, 303–311. [Google Scholar] [CrossRef]
  20. Gaur, P.; Lyons, C.; Malik, T.M.; Kim, M.P.; Blackmon, S.H. Endoluminal suturing of an anastomotic leak. Ann. Thorac. Surg. 2015, 99, 1430–1432. [Google Scholar] [CrossRef]
  21. Burr, N.E.; Everett, S.M. Management of benign oesophageal strictures. Front. Gastroenterol. 2019, 10, 177–181. [Google Scholar] [CrossRef] [PubMed]
  22. Carlson, D.A.; Hirano, I. Narrow-caliber esophagus of eosinophilic esophagitis: Difficult to define, resistant to remedy. Gastrointest. Endosc. 2016, 83, 1149–1150. [Google Scholar] [CrossRef] [PubMed]
  23. Scolapio, J.S.; Pasha, T.M.; Gostout, C.J.; Mahoney, D.W.; Zinsmeister, A.R.; Ott, B.J.; Lindor, K.D. A randomized prospective study comparing rigid to balloon dilators for benign esophageal strictures and rings. Gastrointest. Endosc. 1999, 50, 13–17. [Google Scholar] [CrossRef]
  24. Sami, S.S.; Haboubi, H.N.; Ang, Y.; Boger, P.; Bhandari, P.; de Caestecker, J.; Griffiths, H.; Haidry, R.; Laasch, H.-U.; Patel, P.; et al. UK guidelines on oesophageal dilatation in clinical practice. Gut 2018, 67, 1000–1023. [Google Scholar] [CrossRef] [PubMed]
  25. Kochman, M.L.; McClave, S.A.; Boyce, H.W. The refractory and the recurrent esophageal stricture: A definition. Gastrointest. Endosc. 2005, 62, 474–475. [Google Scholar] [CrossRef]
  26. Boregowda, U. Endoscopic management of benign recalcitrant esophageal strictures. Ann. Gastroenterol. 2021, 34, 287–299. [Google Scholar] [CrossRef]
  27. Li, B.; Zhang, J.-H.; Wang, C.; Song, T.-N.; Wang, Z.-Q.; Gou, Y.-J.; Yang, J.-B.; Wei, X.-P. Delayed gastric emptying after esophagectomy for malignancy. J. Laparoendosc. Adv. Surg. Tech. Part A 2014, 24, 306–311. [Google Scholar] [CrossRef]
  28. Konradsson, M.; Nilsson, M. Delayed emptying of the gastric conduit after esophagectomy. J. Thorac. Dis. 2019, 11 (Suppl. S5), S835–S844. [Google Scholar] [CrossRef]
  29. Bhutani, M.S.; Ejaz, S.; Cazacu, I.M.; Singh, B.S.; Shafi, M.; Stroehlein, J.R.; Mehran, R.J.; Walsh, G.; Vaporciyan, A.; Swisher, S.G.; et al. Endoscopic Intrapyloric Botulinum Toxin Injection with Pyloric Balloon Dilation for Symptoms of Delayed Gastric Emptying after Distal Esophagectomy for Esophageal Cancer: A 10-Year Experience. Cancers 2022, 14, 5743. [Google Scholar] [CrossRef]
  30. Cerfolio, R.J.; Bryant, A.S.; Canon, C.L.; Dhawan, R.; Eloubeidi, M.A. Is botulinum toxin injection of the pylorus during Ivor–Lewis esophagogastrectomy the optimal drainage strategy? J. Thorac. Cardiovasc. Surg. 2009, 137, 565–572. [Google Scholar] [CrossRef]
  31. Anderson, M.J.; Sippey, M.; Marks, J. Gastric Per Oral Pyloromyotomy for Post-Vagotomy-Induced Gastroparesis Following Esophagectomy. J. Gastrointest. Surg. 2020, 24, 715–719. [Google Scholar] [CrossRef] [PubMed]
  32. Mandarino, F.V.; Testoni, S.G.G.; Barchi, A.; Pepe, G.; Esposito, D.; Fanti, L.; Viale, E.; Biamonte, P.; Azzolini, F.; Danese, S. Gastric emptying study before gastric peroral endoscopic myotomy (G-POEM): Can intragastric meal distribution be a predictor of success? Gut 2023, 72, 1019–1020. [Google Scholar] [CrossRef] [PubMed]
  33. Siegal, S.R.; Pauli, E.M. Endoscopic Management of Postoperative Complications. Surg. Clin. N. Am. 2020, 100, 1115–1131. [Google Scholar] [CrossRef] [PubMed]
  34. Carlini, M.; Grieco, M.; Spoletini, D.; Menditto, R.; Napoleone, V.; Brachini, G.; Mingoli, A.; Marcellinaro, R. Implementation of the gut microbiota prevents anastomotic leaks in laparoscopic colorectal surgery for cancer:the results of the MIRACLe study. Updat. Surg. 2022, 74, 1253–1262. [Google Scholar] [CrossRef] [PubMed]
  35. Nakazawa, T.; Uchida, M.; Suzuki, T.; Yamamoto, K.; Yamazaki, K.; Maruyama, T.; Miyauchi, H.; Tsuruoka, Y.; Nakamura, T.; Shiko, Y.; et al. Oral antibiotics and a low-residue diet reduce the incidence of anastomotic leakage after left-sided colorectal surgery: A retrospective cohort study. Langenbeck’s Arch. Surg. 2022, 407, 2471–2480. [Google Scholar] [CrossRef]
  36. Salmeri, N.; Sinagra, E.; Dolci, C.; Buzzaccarini, G.; Sozzi, G.; Sutera, M.; Candiani, M.; Ungaro, F.; Massimino, L.; Danese, S.; et al. Microbiota in Irritable Bowel Syndrome and Endometriosis: Birds of a Feather Flock Together—A Review. Microorganisms 2023, 11, 2089. [Google Scholar] [CrossRef]
  37. Mandarino, F.V.; Sinagra, E.; Barchi, A.; Verga, M.C.; Brinch, D.; Raimondo, D.; Danese, S. Gastroparesis: The Complex Interplay with Microbiota and the Role of Exogenous Infections in the Pathogenesis of the Disease. Microorganisms 2023, 11, 1122. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Mandarino, F.V.; Sinagra, E.; Barchi, A.; Danese, S. The Triple-S Advantage of Endoscopic Management in Gastrointestinal Surgery Complications: Safe, Successful, and Savings-Driven. Life 2024, 14, 122. https://doi.org/10.3390/life14010122

AMA Style

Mandarino FV, Sinagra E, Barchi A, Danese S. The Triple-S Advantage of Endoscopic Management in Gastrointestinal Surgery Complications: Safe, Successful, and Savings-Driven. Life. 2024; 14(1):122. https://doi.org/10.3390/life14010122

Chicago/Turabian Style

Mandarino, Francesco Vito, Emanuele Sinagra, Alberto Barchi, and Silvio Danese. 2024. "The Triple-S Advantage of Endoscopic Management in Gastrointestinal Surgery Complications: Safe, Successful, and Savings-Driven" Life 14, no. 1: 122. https://doi.org/10.3390/life14010122

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop